05:59 PM EDT, 09/23/2024 (MT Newswires) -- BioVie ( BIVI ) said late Monday it plans to sell shares and accompanying warrants in a best efforts public offering, with ThinkEquity as placement agent.

Net proceeds will be used working capital and general corporate purposes, the clinical-stage company said. Investors can also choose to buy pre-funded warrants in lieu of shares.

The shares were down nearly 50% in after-market activity.

Price: 1.4100, Change: -1.39, Percent Change: -49.64